The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson’s disease-Reference-Cited by-同舟云学术

The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson’s disease

Published:2013-10-25 Issue:1 Volume:261 Page:106-116
ISSN:0340-5354
Container-title:Journal of Neurology
language:en
Short-container-title:J Neurol

Author:

Eggington Simon,Valldeoriola Francesc,Chaudhuri K. Ray,Ashkan Keyoumars,Annoni Elena,Deuschl Günther

Publisher

Springer Science and Business Media LLC

Subject

Clinical Neurology,Neurology

Link

http://link.springer.com/article/10.1007/s00415-013-7148-z/fulltext.html

Reference72 articles.

1. Reider CR, Halter CA, Castellucci PF, Oakes D, Nichols WC, Foroud T (2003) Reliability of reported age at onset for Parkinson’s disease. Mov Disord 18(3):275–279

2. Wickremaratchi MM, Perera D, O’Loghlen C, Sastry D, Morgan E, Jones A, Edwards P, Robertson NP, Butler C, Morris HR, Ben-Shlomo Y (2008) Prevalence and age of onset of Parkinson’s disease in Cardiff: a community based cross sectional study and meta-analysis. J Neurol Neurosurg Psychiatry 80(7):805–807

3. Porter B, MacFarlane R, Unwin N, Walker R (2006) The prevalence of Parkinson’s disease in an area of North Tyneside in the North-East of England. Neuroepidemiology 26:156–161

4. Newman EJ, Grosset KA, Grosset DG (2009) Geographical difference in Parkinson’s disease prevalence within West Scotland. Mov Disord 24(3):401–406

5. Morgante L, Nicoletti A, Epifanio A (2008) Prevalence of Parkinson’s disease and other types of parkinsonism in the Aeolian Archipelago, Sicily. Parkinsonism Relat Disord 14(7):572–575

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Devices for remote continuous monitoring of people with Parkinson's disease: a systematic review and cost-effectiveness analysis;HEALTH TECHNOL ASSES;2024

2. Cost Effectiveness of Deep Brain Stimulation for Parkinson’s Disease: A Systematic Review;Applied Health Economics and Health Policy;2023-11-28

3. Cost‐Effectiveness of Carbidopa‐Levodopa Enteral Suspension for Advanced Parkinson's Disease in the United States;Movement Disorders;2023-10-25

4. Economic Evaluations Comparing Deep Brain Stimulation to Best Medical Therapy for Movement Disorders: A Meta-Analysis;PharmacoEconomics;2023-09-26

5. Modelling the Cost Effectiveness of Treatments for Parkinson’s Disease: An Updated Methodological Review;PharmacoEconomics;2023-06-21